Effect of Bilateral Rectointercostal Fascial Plane Block on Postoperative Pain After Laparoscopic… (NCT07253610) | Clinical Trial Compass
CompletedNot Applicable
Effect of Bilateral Rectointercostal Fascial Plane Block on Postoperative Pain After Laparoscopic Sleeve Gastrectomy
Turkey (Türkiye)56 participantsStarted 2025-11-01
Plain-language summary
This randomized controlled study aims to evaluate the effectiveness of the bilateral rectointercostal fascial plane (RIB) block for postoperative pain management in patients undergoing laparoscopic sleeve gastrectomy. The study compares RIB block combined with standard general anesthesia to standard intravenous patient-controlled analgesia alone. The primary outcome is total opioid consumption within the first 24 postoperative hours, while secondary outcomes include pain scores, patient satisfaction, postoperative nausea and vomiting, and block-related complications.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 18 and 65 years
* Body mass index (BMI) \> 35 kg/m²
* American Society of Anesthesiologists (ASA) physical status II-III
* Scheduled for elective laparoscopic sleeve gastrectomy under general anesthesia
* Provided written informed consent to participate in the study
Exclusion Criteria:
* Chronic opioid use or dependence
* History of chronic pain
* Known allergy or contraindication to local anesthetics or opioids
* Severe cardiac, hepatic, or renal disease
* Severe psychiatric disorder (e.g., psychosis, dementia)
* STOP-BANG score ≥ 5 (high risk for obstructive sleep apnea)
* Block failure or incomplete block after local anesthetic injection
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Cumulative Opioid Consumption in the First 24 Hours After Surgery
Timeframe: Postoperative day 1 (0-24 hours after surgery)